Item 2.02 Results of Operations and Financial Condition.
On
The financial results included in the press release are unaudited and
preliminary estimates that (i) represent the most current information available
to management as of the date of this Current Report on Form 8-K, (ii) are
subject to completion of financial closing and procedures that could result in
significant changes to the estimated amounts, and (iii) do not present all
information necessary for an understanding of the Company's financial condition
as of and its results of operations for the quarter ended
In accordance with General Instruction B.2. of Form 8-K, the information in this Item 2.02 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any of the Company's filings under the Securities Act of 1933, as amended (the "Securities Act"), whether made before or after the date hereof, regardless of any incorporation language in such a filing, except as expressly set forth by specific reference in such a filing.
Item 7.01 Regulation FD Disclosure.
On
The information contained in this Item 7.01 and in the accompanying Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any of the Company's filings under the Securities Act, whether made before or after the date hereof, regardless of any incorporation language in such a filing, except as expressly set forth by specific reference in such a filing.
The Company periodically provides information for investors on its corporate
website https://replimune.com/ under the "Investor and Media" section. The
Company intends to use its website as a means of disclosing material non-public
information and for complying with its disclosure obligations under Regulation
FD. Accordingly, investors should monitor the Company's website, in addition to
following the Company's press releases, filings made with the
Item 9.01 Financial Statements and Exhibits.
Exhibit No. ExhibitName 99.1Replimune Group, Inc. Press Release, datedJanuary 11, 2021
© Edgar Online, source